CLINICAL ONCOLOGY PROGRAM

临床肿瘤学项目

• 批准号: 2894572
• 负责人: TIMOTHY J O'ROURKE
• 金额: $ 50.56万
• 依托单位: BUTTERWORTH HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-06-01 至 2000-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2894572
• 关键词: antineoplastics; behavioral /social science research tag; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; chemoprevention; clinical trials; community health services; continuing education; cooperative study; hospitals; human subject; human therapy evaluation; medical rehabilitation related tag; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer therapy; oncology; patient /disease registry; pediatric neoplasm /cancer; pharmacy administration; primary care physician; prostate neoplasms; tamoxifen

Building on nearly 20 years of experience as a model community oncology program,the Grand Rapids Clinical Oncology Program (GRCOP) seeks the opportunity to continue to meet our community's need for innovative and relevant studies of promising therapeutic modalities and cancer control research through the Year 2000. The GRCOP is a regional clinical trials program: a consortium of 8 hospitals within a 29 county service area in Western Michigan. Six components and two affiliates bring together investigators from 5 cities: Grand Rapids, Holland, Battle Creek, Big Rapids, and Traverse city. The service area represents metropolitan and rural populations of over 1.8 million people, or 19.8% of the state's population. The GRCOP provides the only access to clinical trials to several rural counties with low population density. The goal of the Grand Rapids Clinical Oncology Program is to contribute to scientific knowledge and to enhance the level of care in the community through participation in NCI sponsored clinical treatment and cancer control trials. Several aims describe the long-term objectives: to mobilize the existing GRCOP service area resources to increase accrual on NCI protocol studies, including minorities, women, and underserved populations; to provide our Grand Rapids CCOP participants an important opportunity to contribute to national research goals by providing access to the full range of available protocols by our continued work with our CCOP Research Bases, SWOG, CCG, NSABP, and MDACC; to expand our longstanding commitment to cancer prevention and control research, exceeding our past record and retaining adherent participants for the duration of the BCPT & PCPT; and to promote the involvement of primary care providers and other specialists in cancer prevention and control clinical trials. The GRCOP will assist the Public Health Service in achieving the health promotion and disease prevention objectives of Healthy People 2000 as it relates to the health status objectives of cancer and will assist the NCI in its periodic, programmatic evaluation projects. The methods used to achieve these goals include an extensive GRCOP network, a solid organizational base, and an-outstanding data management program. Our GRCOP network incorporates strong links among the medical oncologists (25), multidisciplinary contributors (45), primary care collaborators (170), hospital components and affiliates (8) and consumer representatives within a tightly woven series of community healthcare programs and resources. This network is supported by a solid organizational structure, both adult and pediatric components, a proven and comprehensive data management system for the timely collection and transmission of data to our four research bases with ongoing clinical research Quality Control programs, assuring the highest possible data quality to our research bases for use in analyses and publications. The GRCOP expects to accumulate 330 credits per year in the next funding period, with 121 treatment credits and 209 cancer control credits. The GRCOP will continuously build on prior successes described in the cancer control history and the cancer control illustrations to sustain our innovative cancer control and prevention research programs.

建立在近20年的模型社区肿瘤学经验的基础上 计划，大急流城临床肿瘤学计划（GRCOP）寻求 有机会继续满足我们社区对创新的需求和 有希望的治疗方式和癌症控制的相关研究 在2000年进行研究。 GRCOP是一个区域临床试验计划：共同体8 密歇根州西部29县服务区的医院。六 组件和两个分支机构将来自5个城市的调查员聚集在一起： 大急流城，荷兰，巴特尔克里克，大急流城和特拉弗斯城。这 服务区代表大都市和农村人口1.8以上 百万人口，占该州人口的19.8％。 GRCOP提供了 仅访问临床试验低 人口密度。 大急流城临床肿瘤学计划的目标是为 科学知识并提高社区的护理水平 通过参加NCI赞助的临床治疗和癌症 控制试验。几个目的描述了长期目标： 动员现有的GRCOP服务区域资源以增加应计 NCI方案研究，包括少数民族，妇女和服务不足 人口；为我们的大急流城CCOP参与者提供重要 通过提供访问来为国家研究目标做出贡献的机会 我们与我们的持续合作的全部可用协议范围 CCOP研究基地，SWOG，CCG，NSABP和MDACC；扩大我们的 长期致力于预防癌症和控制研究， 超过我们过去的记录，并保留了遵守参与者 BCPT＆PCPT的持续时间；并促进主要的参与 护理提供者和其他预防和控制方面的专家 临床试验。 GRCOP将协助公共卫生服务 实现健康促进和预防疾病的目标 健康人2000与健康状况的目标有关 癌症，将协助NCI定期进行程序化评估 项目。 用于实现这些目标的方法包括广泛的GRCOP 网络，扎实的组织基础和基于数据管理 程序。我们的GRCOP网络在医疗中结合了牢固的联系 肿瘤学家（25），多学科贡献者（45），初级保健 合作者（170），医院组件和分支机构（8）和消费者 一系列紧密编织的社区医疗保健中的代表 程序和资源。该网络得到坚实的支持 成人和小儿组成部分的组织结构 以及及时收集的全面数据管理系统 将数据传输到我们的四个研究基础上，并进行了持续的临床 研究质量控制计划，确保最高的数据 我们的研究基础的质量用于分析和出版物。 GRCOP预计在下一个资金中每年累积330个积分 时期，具有121个治疗学分和209个癌症控制学分。这 GRCOP将不断建立在癌症中描述的先前成功的基础上 控制历史和癌症控制插图以维持我们的 创新的癌症控制与预防研究计划。